| For: | Romero-Gómez M, Jover M, Díaz-Gómez D, Terán LC, Rodrigo R, Camacho I, Echevarría M, Felipo V, Bautista JD. Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis. World J Gastroenterol 2006; 12(15): 2406-2411 [PMID: 16688834 DOI: 10.3748/wjg.v12.i15.2406] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i15/2406.htm |
| Number | Citing Articles |
| 1 |
Keith Pereira, Andres F. Carrion, Paul Martin, Kirubahara Vaheesan, Jason Salsamendi, Mehul Doshi, Jose M. Yrizarry. Current diagnosis and management of post‐transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy. Liver International 2015; 35(12) doi: 10.1111/liv.12956
|
| 2 |
|
| 3 |
Pauline Bozon-Rivière, Marika Rudler, Nicolas Weiss, Dominique Thabut. TIPS and hepatic encephalopathy in patients with cirrhosis. Metabolic Brain Disease 2025; 40(2) doi: 10.1007/s11011-025-01541-w
|
| 4 |
Chiara Pasquale, Lorenzo Ridola, Oliviero Riggio. Hepatic encephalopathy therapy: An overview. World Journal of Gastrointestinal Pharmacology and Therapeutics 2010; 1(2): 54-63 doi: 10.4292/wjgpt.v1.i2.54
|
| 5 |
M. Jover-Cobos, L. Noiret, K. Lee, V. Sharma, A. Habtesion, M. Romero-Gomez, N. Davies, R. Jalan. Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats. Journal of Hepatology 2014; 60(3) doi: 10.1016/j.jhep.2013.10.012
|
| 6 |
Oliviero Riggio, Silvia Nardelli, Federica Moscucci, Chiara Pasquale, Lorenzo Ridola, Manuela Merli. Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. Clinics in Liver Disease 2012; 16(1) doi: 10.1016/j.cld.2011.12.008
|
| 7 |
Suprabhat Giri, Prajna Anirvan, Mansi Chaudhary, Taraprasad Tripathy, Ranjan Kumar Patel, Mitali Madhumita Rath, Manas Kumar Panigrahi. Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review. British Journal of Radiology 2024; 97(1154) doi: 10.1093/bjr/tqad065
|
| 8 |
Santosh Singh, Papia Mondal, Surendra K. Trigun, Vasu D. Appanna. Acute Liver Failure in Rats Activates Glutamine-Glutamate Cycle but Declines Antioxidant Enzymes to Induce Oxidative Stress in Cerebral Cortex and Cerebellum. PLoS ONE 2014; 9(4) doi: 10.1371/journal.pone.0095855
|
| 9 |
Doo Hee Kim, Hassan Anbari, Sameer Gadani, Baljendra Kapoor. Post-TIPS Encephalopathy: Clinical Presentation, Diagnosis, and Management. Techniques in Vascular and Interventional Radiology 2025; doi: 10.1016/j.tvir.2025.101063
|
| 10 |
Javier Ampuero, Manuel Romero-Gómez. Glutamine in Clinical Nutrition. 2015; doi: 10.1007/978-1-4939-1932-1_18
|
| 11 |
Pilar Carbonero-Aguilar, Maria del Mar Diaz-Herrero, Olga Cremades, Manuel Romero-Gómez, Juan Bautista. Brain biomolecules oxidation in portacaval-shunted rats. Liver International 2011; 31(7) doi: 10.1111/j.1478-3231.2011.02515.x
|
| 12 |
Simon Johannes Gairing, Lukas Müller, Roman Kloeckner, Peter R. Galle, Christian Labenz. Review article: post‐TIPSS hepatic encephalopathy—current knowledge and future perspectives. Alimentary Pharmacology & Therapeutics 2022; 55(10) doi: 10.1111/apt.16825
|
| 13 |
Marta Sidoryk-Wegrzynowicz, Michal Wegrzynowicz, Eunsook Lee, Aaron B. Bowman, Michael Aschner. Role of Astrocytes in Brain Function and Disease. Toxicologic Pathology 2011; 39(1) doi: 10.1177/0192623310385254
|
| 14 |
Nitin K. Ahuja, Winston A. Ally, Stephen H. Caldwell. Direct acting inhibitors of ammoniagenesis: a role in post-TIPS encephalopathy?. Annals of Hepatology 2014; 13(2) doi: 10.1016/S1665-2681(19)30880-4
|
| 15 |
Maria Jover-Cobos, Nathan A. Davies, Yalda Sharifi, Rajiv Jalan. Hepatic Encephalopathy. 2012; doi: 10.1007/978-1-61779-836-8_13
|
| 16 |
Matthew R. Kappus, Jasmohan S. Bajaj. Covert Hepatic Encephalopathy: Not as Minimal as You Might Think. Clinical Gastroenterology and Hepatology 2012; 10(11) doi: 10.1016/j.cgh.2012.05.026
|
| 17 |
Leif Hertz, Geeta Kala. Energy metabolism in brain cells: effects of elevated ammonia concentrations. Metabolic Brain Disease 2007; 22(3-4) doi: 10.1007/s11011-007-9068-z
|
| 18 |
Elena A. Kosenko, Lyudmila A. Tikhonova, Gubidat A. Alilova, Carmina Montoliu, George E. Barreto, Gjumrakch Aliev, Yury G. Kaminsky. Portacaval shunting causes differential mitochondrial superoxide production in brain regions. Free Radical Biology and Medicine 2017; 113 doi: 10.1016/j.freeradbiomed.2017.09.023
|
| 19 |
Luisa Fürschuß, Florian Rainer, Maria Effenberger, Markus Niederreiter, Rupert H. Portugaller, Angela Horvath, Peter Fickert, Vanessa Stadlbauer. A novel score predicts mortality after transjugular intrahepatic portosystemic shunt: MOTS ‐ Modified TIPS Score. Liver International 2022; 42(8) doi: 10.1111/liv.15236
|
| 20 |
Krzysztof Milewski, Małgorzata Bogacińska-Karaś, Wojciech Hilgier, Jan Albrecht, Magdalena Zielińska. TNFα increases STAT3-mediated expression of glutaminase isoform KGA in cultured rat astrocytes. Cytokine 2019; 123 doi: 10.1016/j.cyto.2019.154774
|
| 21 |
Małgorzata Beręsewicz-Haller, Olga Krupska, Paweł Bochomulski, Danuta Dudzik, Anita Chęcińska, Wojciech Hilgier, Coral Barbas, Krzysztof Zablocki, Barbara Zablocka. Mitochondrial Metabolism behind Region-Specific Resistance to Ischemia-Reperfusion Injury in Gerbil Hippocampus. Role of PKCβII and Phosphate-Activated Glutaminase. International Journal of Molecular Sciences 2021; 22(16) doi: 10.3390/ijms22168504
|
| 22 |
Jingjing Song, Weiye Lu, Shengli Yang, Fazong Wu, Zhongwei Zhao, Jiansong Ji. Effects of shunt embolization on hepatic encephalopathy recurrence in patients with major portosystemic shunts: A systematic review and meta‑analysis. Biomedical Reports 2025; 22(4) doi: 10.3892/br.2025.1950
|
| 23 |
Piero Amodio. The liver, the brain and nitrogen metabolism. Metabolic Brain Disease 2009; 24(1) doi: 10.1007/s11011-008-9120-7
|